Leveraging the Treg-intrinsic CTLA4–PKCη signaling pathway for cancer immunotherapy

BACKGROUND: Our previous studies revealed a critical role of a novel CTLA4-protein kinase C-eta (PKCη) signaling axis in mediating the suppressive activity of regulatory T cells (Tregs) in antitumor immunity. These studies have employed adoptive transfer of germline PKCη-deficient (Prkch(−/−)) Tregs...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Hsin-Yu, Pedros, Christophe, Kong, Kok-Fai, Canonigo-Balancio, Ann J, Xue, Wen, Altman, Amnon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Basic Tumor Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483050/
https://www.ncbi.nlm.nih.gov/pubmed/34588224
http://dx.doi.org/10.1136/jitc-2021-002792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483050/
https://www.ncbi.nlm.nih.gov/pubmed/34588224
http://dx.doi.org/10.1136/jitc-2021-002792

Ejemplares similares